Events

Events

Upcoming Events
Sep 5 - Sep 8, 2019

Thursday, September 5, 2019
11:59am CEST
Presentation by Pravin U. Dugel, M.D.

Session: Novelties and Late Breaking Developments in Retina & Technology

Title: Novel anti-VEGF antibody biopolymer conjugate KSI-301 with potential for extended durability in retinal vascular diseases: first-time results from a phase 1b study in patients with wAMD, DME and RVO

 

Sunday, September 8, 2019
9:48am CEST
Presentation by Pravin U. Dugel, M.D.

Free Paper Session

Title: Extended durability in exudative retinal diseases using a new class of molecules: novel anti-VEGF antibody biopolymer conjugate KSI-301: first-time results of the phase 1b study in patients with wAMD, DME and RVO

Paris, France
Sep 11 - Sep 15, 2019

Sunday, September 15, 2019
11:08am BST
Presentation by David Brown, M.D.

Novel Anti-VEGF Antibody Biopolymer Conjugate KSI-301 with Potential for Extended Durability in Retinal Vascular Diseases: Late-Breaking Results from a Phase 1b Study in Patients with wAMD, DME and RVO

London, UK
Past Events
Jul 26 - Jul 30, 2019

Saturday, July 27, 2019

11:48am CDT

Presentation by Pravin U. Dugel, M.D.

Antibody Biopolymer Conjugates: A Novel Scientific Approach and Platform for Extended-Durability Retinal Medicines - First Results from a Phase 1b Proof of Concept Study of KSI-301, an anti-VEGF ABC

Chicago, IL
Feb 9, 2019
2:30pm ET

Presentation by Diana V. Do, M.D.
KSI-301: Update on Phase 1 Studies with a First in Class Antibody-Biopolymer Conjugate for Treatment of Wet AMD, DME, and Other Retinal Vascular Diseases

Miami, FL